They'll say something like "take your dose as soon as you remember, unless it's almost time for your next dose." This is wrong for semaglutide because the risks are asymmetric: Late dose (taken 1 to 2 days after scheduled day): Blood levels drop slightly below target Appetite suppression weakens temporarily No increased side effect risk No safety concern Easy fix: take the dose when you remember, resume normal schedule Early dose (taken 1 to 2 days before scheduled day): Blood levels rise slightly above target Appetite suppression unchanged Modest increase in GI side effect risk Generally safe for one-time occurrence Risk increases if it becomes a pattern The standard advice to "take it when you remember" works fine for late doses
Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liragltuide
July 2024: A study published in JAMA Ophthalmology suggests that Ozempic users could be at higher risk of NAION, a condition that can cause sudden and permanent vision loss
Purified Water, Ethylhexyl Palmitate, Glycereth-26, Glycerin, Cetearyl Alcohol, Niacinamide, Hydrogenated Poly(C6-14 Olefin), Beeswax, Caprylic/Capric Triglyceride, Polyglyceryl-2 Stearate, Dipropylene Glycol, Isododecane, Glyceryl Stearate, Hydroxyethyl Acrylate/Sodium Acryloyldimethyl Taurate Copolymer, Stearyl Alcohol, Glycol Stearate SE, Sodium Polyacrylate, Hydroxyacetophenone, Stearic Acid, Dimethiconol, Dimethicone/Vinyl Dimethicone Crosspolymer, Hydrogenated Polydecene, Hydrogenated Lecithin, Tranexamic Acid (1,000ppm), Betaine, Glutathione (1,000ppm), Panthenol, Fragrance, Hippophae Rhamnoides Fruit Oil, Butylene Glycol, Adenosine, Sorbitan Isostearate, Caprylyl Glycol, Trideceth-6, 1,2-Hexanediol, Disodium EDTA, Sodium Hyaluronate, Ascorbic Acid
After testing in patients without type 2 diabetes, the FDA approved Wegovy (for chronic weight management)
When a long-chain fatty acid enters the cell, it is first activated into an acyl-CoA molecule